Centamin Egypt Limited
23 November 2007
CENTAMIN EGYPT LIMITED ANNOUNCES CLOSING OF C$134,400,000 SPECIAL WARRANT
FINANCING
Centamin Egypt Limited (TSX:CEE) (AIM:CEY) (ASX:CNT) is pleased to announce that
it has closed the previously announced offering of special warrants (the '
Offering'), sold on a private placement basis through a syndicate of
underwriters led by Westwind Partners Inc. and including Orion Securities Inc.,
Ambrian Partners Limited and Cormark Securities Inc. (collectively, the '
Underwriters'). An aggregate of 112,000,000 special warrants were issued and
sold today at a price of C$1.20 per special warrant for aggregate gross proceeds
of C$134,400,000, which includes the exercise in full by the Underwriters of the
Underwriters' option.
The Offering was subject to shareholder approval of 75,893,863 ordinary shares
and 8,794,691 broker warrants that were issued in April 2007, which was received
at the Company's annual meeting held today.
Each special warrant shall be automatically exercised for no additional
consideration to acquire one ordinary share in the capital of the Company,
subject to adjustment in certain events, at 5:00pm (Toronto time) on the earlier
of (a) the third business day after the date that a receipt is issued by the
securities regulatory authorities in Canada for a final prospectus qualifying
the ordinary shares to be issued upon the exercise of the special warrants and
(b) the date that is four months and one day following the closing date of the
Offering.
Centamin Egypt Limited plans to use the net proceeds of this financing to fund
the continued development of the Sukari gold project, underground development,
other exploration and general corporate purposes. The Underwriters received
compensation comprised of cash upon closing of the Offering and will also be
issued broker warrants subject to shareholder approval prior to issuance.
The securities issued under this Offering were offered by way of private
placement exemptions in all the provinces of Canada other than Quebec, offshore
including in the United Kingdom pursuant to applicable exemptions and in the
United States on a private placement basis pursuant to exemptions from the
registration requirements of the United States Securities Act of 1933, as
amended.
The securities offered have not been, nor will they be, registered under the
United States Securities Act of 1933, as amended, and were not offered or sold
within the United States or to, or for the account or benefit of, U.S. persons
absent U.S. registration or an applicable exemption from the U.S. registration
requirements. This release does not constitute an offer for sale of securities
in the United States.
For Centamin Egypt Limited
Josef El-Raghy
Managing Director/CEO
23 November 2007
For more information please contact:
Centamin Egypt Limited Pelham Public Relations Ambrian Partners Limited
+ 61 (8) 9316 2640 + 44 (0) 207 743 6376 + 44 (0) 207 776 6400
Josef El-Raghy Candice Sgroi Richard Brown
www.centamin.com Mobile: + 44 (0) 7894 462 114
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.